Target EphA2 receptor for cancer therapy

被引：0
|
作者：
Wang, Si [1 ]
Stebbins, John [1 ]
Noberini, Roberta [1 ]
Zhang, Ziming [1 ]
Pellecchia, Maurizio [1 ]
Pasquale, Elena [1 ]
Kitada, Shinichi [1 ]
Fisher, Paul [1 ]
机构：
[1] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92130 USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2013年 / 245卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
342-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] EphA2 as a target for ovarian cancer therapy
    Landen, CN
    Kinch, MS
    Sood, AK
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (06) : 1179 - 1187
  • [2] EphA2 receptor tyrosine kinase as a promising target for cancer therapeutics
    Ireton, RC
    Chen, J
    CURRENT CANCER DRUG TARGETS, 2005, 5 (03) : 149 - 157
  • [3] EPHA2: A novel target for prostate cancer treatment
    Zeng, G
    Hu, ZQ
    Zhang, SB
    Li, L
    Baldridge, LA
    Kao, CH
    Gardner, TA
    Koch, MO
    Ulbright, TM
    Eble, JN
    Cheng, L
    JOURNAL OF UROLOGY, 2004, 171 (04): : 482 - 482
  • [4] EphA2: A promising therapeutic target in breast cancer
    Zhao, Ping
    Jiang, Dewei
    Huang, Yunchao
    Chen, Ceshi
    JOURNAL OF GENETICS AND GENOMICS, 2021, 48 (04) : 261 - 267
  • [5] EphA2: A promising therapeutic target in breast cancer
    Ping Zhao
    Dewei Jiang
    Yunchao Huang
    Ceshi Chen
    Journal of Genetics and Genomics, 2021, 48 (04) : 261 - 267
  • [6] THE TYROSINE KINASE RECEPTOR EPHA2 IS A DRUG TARGET FOR OSTEOARTHRITIS
    Ferrao Blanco, M. N.
    Bastiaansen-Jenniskens, Y. M.
    Narcisi, R.
    Chambers, M. G.
    Pitsillides, A. A.
    van Osch, G. J.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S36 - S37
  • [7] EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections
    Vincenzi, Marian
    Mercurio, Flavia Anna
    Leone, Marilisa
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (35) : 5670 - 5701
  • [8] A novel EphA2 receptor tyrosine kinase inhibitor Compound A for targeted cancer therapy
    Li, Q. John
    Shi, Manli
    Qiu, Ming
    Los, Gerrit
    CANCER RESEARCH, 2009, 69
  • [9] Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
    Quinn, Bridget A.
    Wang, Si
    Barile, Elisa
    Das, Swadesh K.
    Emdad, Luni
    Sarkar, Devanand
    De, Surya K.
    Kharagh, Susan Morvaridi
    Stebbins, John L.
    Pandol, Stephen J.
    Fisher, Paul B.
    Pellecchia, Maurizio
    ONCOTARGET, 2016, 7 (13): : 17103 - 17110
  • [10] EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia
    Charmsaz, Sara
    Beckett, Kirrilee
    Smith, Fiona M.
    Bruedigam, Claudia
    Moore, Andrew S.
    Al-Ejeh, Fares
    Lane, Steven W.
    Boyd, Andrew W.
    PLOS ONE, 2015, 10 (06):
12345